SonoThera, Inc.

Venture-backed company · Stage unknown· South San Francisco, CAsonotherabio.com
Rounds on record
2
Latest round
Jun 8, 2026
Form D equity offering
Latest round size
$125M
As of · the latest observation of this company; each round carries its own date

3 additional officers and directors, 1 additional investor

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. $125M
    sold on Form D

    Filed a Form D on 8 Jun 2026: $125M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.

    A company that just raised has fresh capital, a new board and new vendors to choose.

    FactSEC Form DFor Investors, lenders, service providersFinancing history →
  2. 2 investors
    named

    2 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  3. 5 directors
    board

    5 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2

Financing history

2 rounds
  1. Jun 8, 2026
    Form D equity offering · $125M (form d sold) · 22 investors
    Arch Venture Partners via Steven Nmn Gillis
    Fact Form D · “SonoThera, Inc. filed Form D: $125,450,218 sold of $125,450,218, Biotechnology”
  2. Apr 29, 2022
    Form D equity offering · $30.4M (form d sold)
    Arch Venture Partners via Steven Nmn Gillis
    Fact Form D · “SonoThera, Inc. Form D, first filed 2022-12-29”

Who would invest

2 investors on record, then the firms most like them

Already invested

2 investors on record

Strong comparable investors

0 firms

Firms that backed two or more of the companies this company's own investors also back.

No firm backed two or more of the companies this company's investors back, so there is no comparable investor on record yet.

Broader fit

6 firms

Firms that co-invest repeatedly with this company's investors and dated a new company in the last 12 months.

  1. Decheng Capital LLC
    • Co-invested 6 times with 1 of this company's investors
    • Has joined rounds of $50M to $150M (4 on record)
    • Invests in Life sciences
    • 3 new companies dated in the last 12 months, latest Aug 14, 2026
    • Followed on in 22% of its companies
  2. Catalio Capital Management, LP
    • Co-invested 5 times with 1 of this company's investors
    • Has joined rounds of $50M to $150M (3 on record)
    • Invests in Life sciences
    • 3 new companies dated in the last 12 months, latest Sep 23, 2026
    • Led 50% of 4 rounds whose lead is known
  3. Foresite Capital
    • Co-invested 5 times with 1 of this company's investors
    • Has joined rounds of $50M to $150M (2 on record)
    • Invests in Life sciences
    • 1 new company dated in the last 12 months, latest Mar 26, 2026
    • Followed on in 33% of its companies

+3 more broader-fit firms

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Ownership and outcomes

none on record
Outcome stated by investors

Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 1 listingeach firm's own card, as read
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

4 officers, 5 directors
Show all 6 officers and directors

Timeline

1 event
  1. Jun 30, 2026
    SonoThera, Inc. filed Form D: $125,450,218 sold of $125,450,218, Biotechnology
    Form D filed Fact Form D

Evidence

19 observations
Every observation on this company
  • Entity type: Corporation Jun 30, 2026 Fact Form D
  • Form D industry group: Biotechnology Jun 30, 2026 Fact Form D
  • Amendment: false Jun 30, 2026 Fact Form D
  • Revenue range (Form D): Decline to Disclose Jun 30, 2026 Fact Form D
  • Incorporated: withinFiveYears Jun 30, 2026 Fact Form D
  • Jurisdiction: Delaware Jun 30, 2026 Fact Form D
  • Amount sold (Form D): $125M Jun 30, 2026 Fact Form D
  • Offering amount (Form D): $125M Jun 30, 2026 Fact Form D
  • Exemptions: 06c Jun 30, 2026 Fact Form D
  • First sale: 2026-06-08 Jun 30, 2026 Fact Form D
  • Investors (Form D): 22 Jun 30, 2026 Fact Form D
  • Minimum investment (Form D): 0 Jun 30, 2026 Fact Form D
  • Securities offered: equity Jun 30, 2026 Fact Form D
  • Office address: Jun 30, 2026 Fact Form D
  • Listed on portfolio page: Sep 30, 2026 Fact
  • Listed on portfolio page: Sep 16, 2026 Fact
  • Listed on portfolio page: Sep 14, 2026 Fact
  • Website status: redirected:sonothera.com Sep 28, 2026 Fact Company website
  • Year of incorporation: 2021 Jun 30, 2026 Fact Form D

Relationships across DFX

on 1 other DFX graph
Across the graphs

SonoThera, Inc. is the same institution as 2 records in Private Equity.

Private Equity2

DFX found 2 relationships across 1 dataset

Which record it is in each graph, what it is called there, and how the two were matched.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Checking your plan…

Record history

2 identity changes, 1 dated event on the change ledger, latest event first
  • Listing repointed
    2026-10-01source on record
  • Identifier moved
    2026-10-01
  • Form D filed
    2026-06-30source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.